Susanne Merkel

31PUBLICATIONS
78CO-AUTHORS
Predictive and prognostic markersAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Experimental methods in fluid flow, heat and mass transferImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jun 12, 2026
Post-Surgical Remodeling of Circulating Monocytes Identifies CD86 Expression on Non-Classical Monocytes as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.

|Apr 28, 2026
Fibroblast dynamics in colorectal cancer: stability, plasticity, and novel markers.

|Mar 14, 2026
Immune Cell-Specific and Isoform-Selective Regulation of CD44 in Pancreatic Ductal Adenocarcinoma Links Lymph Node Variant Loss and Exosomal CD44 to Clinical Outcome in Pancreatic Ductal Adenocarcinoma.

Alara Karabiber, Yong Zhou, Anke Mittelstädt

|Nov 13, 2025
The Prognostic Role of Para-Aortic Lymph Node Metastasis in Patients with Resected Pancreatic Adenocarcinoma.

Maximilian Brunner, Lena Kitzke, Anke Mittelstädt

|Apr 17, 2025
Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma Patients.

Isabelle Kuchenreuther, Finn-Niklas Clausen, Johanne Mazurie

|Feb 26, 2025
Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma.

Paul David, Dina Kouhestani, Frederik J Hansen

Pageof 6

Frequent Collaborators

14 joint publications

Georg F Weber

12 joint publications

Christian Krautz

5 joint publications

Anke Mittelstädt

5 joint publications

Paul David